Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2010
08/18/2010CN101808638A Antifungal composition
08/18/2010CN101808637A Pharmaceutical composition
08/18/2010CN101808628A Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient
08/18/2010CN101808619A Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant
08/18/2010CN101808533A Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
08/18/2010CN101805465A Photocrosslinking nano hydrogel and preparation method thereof
08/18/2010CN101805343A Chemically modified small molecules
08/18/2010CN101805334A Lamivudin stearate and synthesis method and application
08/18/2010CN101804209A PEDF (Pigment Epithelial Derived Factor) gene PLGA nano compound as well as preparation method and use thereof
08/18/2010CN101804206A Porous calcium phosphate microsphere with medicinal controlled release function, preparation method and application thereof
08/18/2010CN101804202A Methods of producing influenza vaccine compositions
08/18/2010CN101804200A Broad spectrum anti-viral therapeutics and prophylaxis
08/18/2010CN101804198A Combination containing fotemustine
08/18/2010CN101804178A Preparation method of plaster used for treating mammary gland hyperplasia and application thereof
08/18/2010CN101804177A Anti-depressive traditional Chinese medicinal composition and dripping pill
08/18/2010CN101804145A Garlic oil enteric pellet capsule and preparation method thereof
08/18/2010CN101804084A Solid dispersion and preparation method thereof
08/18/2010CN101804069A Concentrated disinfectant for nipples of dairy cows
08/18/2010CN101804056A Compound tablet of pioglitazone hydrochloride, glimepiride and preparation method thereof
08/18/2010CN101804053A Chiral benzo-quinoline hydrochloride-2-carboxylic acid arginine salt composite and preparation and application thereof
08/18/2010CN101804052A Liposome injection based on drug combination of mezlocillin sodium and sulbactam sodium
08/18/2010CN101804051A Liposome injection of pharmaceutical composition of amoxicillin sodium and clavulanate potassium
08/18/2010CN101804048A Antiparasitic composition for animal
08/18/2010CN101804041A Controlled release compositions comprising nimesulide
08/18/2010CN101804038A Huperzine A preparation for treating schizophrenia and nervous function damage and preparation method thereof
08/18/2010CN101804037A Acyclovir dispersible tablet and preparation method thereof
08/18/2010CN101804036A 多潘立酮口腔崩解片及其制备方法 Domperidone orally disintegrating tablets and its preparation method
08/18/2010CN101804035A Lansoprazole preparation for injection and preparation method thereof
08/18/2010CN101804034A Rabeprazole sodium powder injection and preparation method thereof
08/18/2010CN101804033A Atenolol non-pH-dependent sustained release pellets and preparation method thereof
08/18/2010CN101804032A Preparation method of 5-fluorouracil-wrapped biodegradable polylactic acid/nano-hydroxyapatite compound microspheres
08/18/2010CN101804031A Preparation method of ribavirin-quaternized chitosan nanoparticles
08/18/2010CN101804030A Sodium dichlorophenolate micro-pill pharmaceutical preparation and preparation method thereof
08/18/2010CN101804027A Granisetron hydrochloride nasal spray and preparation method thereof
08/18/2010CN101804026A Preparation of interferon fat emulsion for injection
08/18/2010CN101804025A Aqueous solution injection for picoplatin
08/18/2010CN101804021A Preparation method of polyene-containing taxol nanoparticle mixed micelle preparation and freeze-drying agent
08/18/2010CN101623263B Cefminox sodium liposome preparation
08/18/2010CN101623260B Cefepime hydrochloride proliposome preparation
08/18/2010CN101601656B Edaravone liposome injection and new application thereof
08/18/2010CN101601654B Hydrochloric acid Fasudil liposome injection and new application thereof
08/18/2010CN101548957B Sub-micro emulsion frozen preparation of pantoprazole sodium prepared by using multiple emulsion method
08/18/2010CN101548956B Sub-micro emulsion frozen preparation of aztreonam
08/18/2010CN101536995B High imbibition dissoluble drug release external contraceptive membrane
08/18/2010CN101507723B Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof
08/18/2010CN101416944B Sodium ferulic acid nano micelle preparation and preparation method thereof
08/18/2010CN101342145B Medicinal fine pellet core and preparation method
08/18/2010CN101284011B Oleanolic acid orally disintegrating tablet and preparation method thereof
08/18/2010CN101254178B Gliclazide controlled release tablets
08/18/2010CN101240028B Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine
08/18/2010CN101234102B Peperphentonamine hydrochloride freeze-dried injection and preparation and application thereof
08/18/2010CN101167705B Composition for preparing plant hollow hard capsule and preparation method of capsule
08/18/2010CN101134785B Colonic microflora degradation material and preparation method and uses thereof
08/18/2010CN101024076B Novel use of coccidium
08/18/2010CN101019911B Chinese medicine composition possessing antifatigue and immunoregulation functions
08/17/2010US7779020 Small-footprint applicative query interpreter method, system and program product
08/17/2010US7777019 nucleic acid encoding the antibodies conjugated to radioisotope, drug, cytotoxic agent or biodrug; immunotoxin of use to treat cancer; immunoassay kit for detection of CD 22+ cancer cells; lymphoma
08/17/2010US7777012 Method of preparing a protein aggregate and a pharmaceutical preparation
08/17/2010US7776926 Blend of a biologically compatible structural component such as an acrylic ester (co)polymer, and a copolymer having a biobeneficial or bioactive moiety, such as a block copolymer of polyethylene glycol and a polyacrylate; coating medical devices such as stents
08/17/2010US7776899 Mixture of phentolamine mesylate, papaverine hydrochloride and alprostadil with buffer; injecting into penis
08/17/2010US7776814 with cyclodextrins, polyoxyethylene glycol; anticancer agents
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776577 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
08/17/2010US7776369 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis
08/17/2010US7776367 modifying surface of skin by giving skin smoother appearance through reduction of depth of wrinkles and fine lines and/or by providing skin with a re-plumping effect by applying a cosmetic composition comprising an extract of an exudate of the plant Daniellia oliveri
08/17/2010US7776366 improve fertility in mammals, including humans and stallions, including an oil cake component, glucosamine derivative, an acid, minerals, vitamins, and a food component, gametogenesis
08/17/2010US7776359 mixture of dextran polymer grafted with homo-oligomers of L-lactic acid, and dextran polymer grafted with homo-oligomers of D-lactic acid in an aqueous system,wherein homo-oligomers of L-lactic acid and homo-oligomers of D-lactic acid have 7-25 lactic acid monomers on average; biodegradable
08/17/2010US7776354 Remedies for glomerular diseases
08/17/2010US7776353 producing food product containing conjugated linoleic acid esters by combining foodstuff with a conjugated linoleic acid ester composition containing less than 1% total 8,10 octadecadienoic acids, 11,13 octadecadienoic acids, and trans-trans octadecadienoic acids, adding adsorbing agent, antioxidant
08/17/2010US7776351 polysiloxane prepolymers with pendant pharmaceutically active leaving groups that are released when hydrolyzed or cured in situ
08/17/2010US7776345 Gastric retention controlled drug delivery system
08/17/2010US7776344 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects
08/17/2010US7776343 comprising a negatively charged organic carrier and a positively charged antigen; for facilitating the induction of a cytotoxic T-lymphocyte response to an antigen
08/17/2010US7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
08/17/2010US7776339 dermatocosmetic composition for treating or reducing skin wrinkles; comprising a proteinaceous extract of Rhizomucor miehei free of acid-protease activity; wrinkle resistance; aging resistance; collagen regeneration; tissue engineering
08/17/2010US7776324 Cancer vaccine
08/17/2010US7776319 Methods and compositions for treatment of ion imbalances
08/17/2010US7776310 non-polymeric biodegradable implantable seeds
08/17/2010CA2585003C An oral preparation having improved bioavailability
08/17/2010CA2473203C Orodispersible pharmaceutical composition comprising ivabradine
08/17/2010CA2473201C Orodispersible pharmaceutical composition comprising agomelatine
08/17/2010CA2418967C Improved hard sugar coating method
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2318008C Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
08/17/2010CA2302522C Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2200695C Cationic transport reagents
08/12/2010WO2010091287A1 Process for purifying guar
08/12/2010WO2010091206A1 Compositions and uses to govern cancer cell growth
08/12/2010WO2010091198A1 Therapeutic compositions comprising monoterpenes
08/12/2010WO2010091192A2 Nanoscale platinum compounds and methods of use thereof
08/12/2010WO2010091187A2 Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
08/12/2010WO2010090850A1 Methods for treating or preventing radiocontrast agent induced kidney injury
08/12/2010WO2010090677A1 Clostridial toxin pharmaceutical compositions
08/12/2010WO2010090654A1 Methods of reducing the proliferation and viability of microbial agents
08/12/2010WO2010090612A1 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
08/12/2010WO2010090371A1 Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process
08/12/2010WO2010090346A1 Film base for adhesive patch, and adhesive patch
08/12/2010WO2010090222A1 Hb-egf-bound protein complex
08/12/2010WO2010090172A1 Pharmaceutical composition for oral administration
1 ... 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 ... 1712